SCHEMBL10502534

SCHEMBL10502534

O=[N+]([O-])c1cnc(-n2[se]c3ccccc3c2=S)s1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MPI P34949 1/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ ALDH1A1 P00352 2/20 0.38
▸ HPGD P15428 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ ATG4B Q9Y4P1 5/20 0.37
▸ MEN1 O00255 4/20 0.36
▸ NPC1 O15118 4/20 0.36
▸ KMT2A Q03164 4/20 0.36
▸ RAB9A P51151 3/20 0.36
▸ MAPT P10636 2/20 0.36
▸ HTT P42858 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ CDK2 P24941 1/20 0.36
▸ GSK3A P49840 1/20 0.36
▸ GSK3B P49841 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5916758 0.86 MPI (0.58) MPISMN1; SMN2CYP1A2CYP3A4TSHR
SCHEMBL10501392 0.77 METAP2 (0.34) MPICYP3A4HSD17B10ALDH1A1HPGD
SCHEMBL10502231 0.77 METAP2 (0.37) MPICYP3A4HSD17B10ALDH1A1HPGD
SCHEMBL10747422 0.76 MEN1 (0.41) MPISMN1; SMN2CYP3A4TSHRHSD17B10
SCHEMBL10501715 0.74 MEN1 (0.46) CYP1A2ALDH1A1HPGDMEN1KMT2A
SCHEMBL10502218 0.74 CYP1A2 (0.47) SMN1; SMN2CYP1A2ALDH1A1NPC1RAB9A
SCHEMBL10501763 0.74 ALDH1A1 (0.44) MPICYP1A2CYP3A4TSHRHSD17B10
SCHEMBL10748117 0.72 PIN1 (0.45) —
SCHEMBL10503512 0.71 ALDH1A1 (0.44) MPICYP3A4HSD17B10ALDH1A1HPGD
SCHEMBL10745614 0.70 METAP2 (0.35) MPICYP3A4HSD17B10ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0154851-B1 BENZISOSELENAZOLETHIONES,PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PRODUCTS CONTAINING THESE COMPOUNDS A. Nattermann & Cie. GmbH (DE) 1989-08-02 — — EP disclosed
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
EP-0154851-A1 Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds A. Nattermann & Cie. GmbH (DE) 1985-09-18 — — EP disclosed
Send feedback